Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 30Peritoneal Neoplasms 24Ovarian Neoplasms 24Fallopian Tube Neoplasms 13Carcinoma, Ovarian Epithelial 12Colorectal Neoplasms 11Neoplasm Metastasis 5Appendiceal Neoplasms 5Recurrence 3Pancreatic Neoplasms 3Neoplasms 3Uterine Neoplasms 2Sarcoma 2Pseudomyxoma Peritonei 2Mesothelioma 2Hyperthermic Intraperitoneal Chemotherapy 2Gastric Adenocarcinoma 2Desmoplastic Small Round Cell Tumor 2Colonic Neoplasms 2Carcinoma 2Wilms Tumor 1Uterine Cervical Neoplasms 1Stage â…¢ Gastric Cancer 1Rhabdomyosarcoma 1Rectal Neoplasms 1Peritoneal Metastases From Gastric Cancer 1Peritoneal Metastases From Colorectal Cancer 1Peritoneal Diseases 1Pelvic Neoplasms 1Ovarian Epithelial Cancer Recurrent 1

Interventions

apatinib 1Neoadjuvant Therapy 1Laparotomy 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Peritoneal Metastases From Gastric Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT03349827 2020-03-24

HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric Cancer

Wuhan University

Phase NA Terminated
20 enrolled
Gastrointestinal

Peritoneal Metastases From Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡